SCHEMBL12374464

SCHEMBL12374464

Cc1cc(=O)nc(NC(=O)NC(NC(=O)Nc2nc(=O)cc(C)[nH]2)NC(=O)Nc2nc(=O)cc(C)[nH]2)[nH]1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB4A P04350 2/20 0.33
▸ TUBB P07437 2/20 0.33
▸ TUBA3C P0DPH7 2/20 0.33
▸ TUBA1B P68363 2/20 0.33
▸ TUBA4A P68366 2/20 0.33
▸ TUBB4B P68371 2/20 0.33
▸ TUBB3 Q13509 2/20 0.33
▸ TUBB2A Q13885 2/20 0.33
▸ TUBB8 Q3ZCM7 2/20 0.33
▸ TUBA3E Q6PEY2 2/20 0.33
▸ TUBA1A Q71U36 2/20 0.33
▸ TUBA1C Q9BQE3 2/20 0.33
▸ TUBB6 Q9BUF5 2/20 0.33
▸ TUBB2B Q9BVA1 2/20 0.33
▸ TUBB1 Q9H4B7 2/20 0.33
▸ ABL1 P00519 6/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13051269 0.89 GAA (0.38) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL11988255 0.88 TUBB4A (0.35) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL11988257 0.87 TUBB4A (0.34) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL21730564 0.84 RAB9A (0.43) ABL1KDM4EALDH1A1RAB9AMEN1
SCHEMBL9070685 0.84 SMN1; SMN2 (0.39) ABL1KDM4EALDH1A1GDAFGFR1
SCHEMBL21122922 0.83 KDM4E (0.39) KDM4EALDH1A1HPGDFGFR1FGFR2
SCHEMBL13521764 0.82 FGFR1 (0.32) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL12374457 0.81 ABL1 (0.40) ABL1GAARAB9AMEN1NPC1
SCHEMBL12374474 0.81 ABL1 (0.37) ABL1
SCHEMBL13287240 0.80 KDM4E (0.47) KDM4EALDH1A1ESR1HPGDGDA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575341-B2 Cosmetic composition, cosmetic treatment method, and compound L'OREAL (FR) 2013-11-05 — — US disclosed
US-20110189118-A1 COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND L'OREAL (FR) 2011-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110189118-A1 COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND KRT18, MC1R, C1R TUBB4A 1194/4885TUBB 775/4885TUBA3C 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback